Skip to main content
Premium Trial:

Request an Annual Quote

Knome Nets Contract to Analyze 1K Genomes for Johns Hopkins Project

Premium

Knome said this week that it has been contracted by Johns Hopkins University's School of Medicine to provide informatics services and software tools for a JHU-led study focused on finding genetic variants linked to asthma in African American and African Caribbean populations.

Knome will use its platform to annotate data from 1,000 genomes contributed by 15 academic research centers across the United States, the Caribbean, and South America as well as from four research sites in Western Africa as part of the study.

Additionally, JHU researchers will use the company’s informatics tools to shortlist candidate causal variants, genes, and gene networks, Knome said.

The Cambridge, Mass.-based company spun out its new informatics software-as-a-service product called KnomeBase last November, for clients that require only genome interpretation services. Its toolkit includes KnomeVariants, which is a query tool for finding candidate causal variants, and KnomePathways, a visualization tool that overlays genomic variants onto gene interaction and co-expression networks to help users identify functional interactions between variants (BI 12/22/2011).

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.